| Micro-channel |
 |
|
|
|
|
|
| |
| The proportion of single drug stores fell to 50.63 percent, and the retail terminal 3 major new trend |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-18 11:18:46 Number Browse：706 |
| |
Medical network - on August 18, according to the development of Chinese pharmaceutical market of 2017 blue book (hereinafter referred to as the "blue book"), drug retail terminal to the latest figures released in 2016 pharmacy in our country is 44.7 m, total fell 0.23%. The new GSP has continuously raised the operating threshold of retail pharmacies, and the strengthening of supervision has also made the retail pharmacies to be rectified and regulated, so that the total number of pharmacies has been slowed down. According to the blue book, the proportion of independent pharmacies continued to decline to 50.63 percent, and the living space of the independent pharmacies kept narrowing.
In the policy guide, health industry upgrading, such as consumer demand change, drug retail end tend to be more reasonable, the management mode of retail pharmacies to service, medical treatment, pharmacy to survive must depend on the size and the professional service ability. In particular, the development of retail pharmacy terminal in the past year has the following new trend.
Three factors pull down overall growth
Drugstore growth was slower than in previous years, with prescription drugs, freight peers and zero rates
According to the latest statistics from minnet, the market share of drug retail sales in the first half of 2017 is equal to that of 2016, accounting for 22.5 percent of the big three terminals. Sales of terminal drugs in retail pharmacies kept growing, but the growth rate slowed, with sales in the first half of 2017 reaching 181.3 billion yuan, up 8.0% year on year (see figure 1).
Retail pharmacy terminals contain two major markets: physical drugstores and online pharmacies. In the first half of 2017, the sales volume of physical drugstores was 177.8 billion yuan, and the corresponding increase was 7.5% (see figure 2). Drug sales in the online pharmacy market were 3.5 billion yuan, up 45.8% from the previous year due to the small base (see figure 3).
"There are several reasons for the increase in the number of physical drugstores in the past year. For example, the local drug administration has stepped up its efforts to check pharmacies for prescription drug purchases. The competitive effect of the zero rate of community medical institutions and the "freight forwarders". Minnet general manager/lead researcher zhang gai pointed out.
"The new GSP emphasizes the establishment of a commodity information system, which requires the payment of goods in accordance with the payment of goods, but at the moment it is not the same." Li congyi, general manager of the OTC business division of kangmei pharmaceutical co., also pointed out that this means more tax management and higher tax costs. Whatever want tax bill, commercial companies must offer tax bill, "don't cheaper tax bill will be unsustainable," means that there would be no price advantage small chain and constructions, more competitive in chain.
In addition, also have market professionals think, 2017 years later, can't have too big change in the retail market, and even may be due to the implementation of the hierarchical diagnosis and treatment, doctors at the grass-roots level ability of the drug, affect retail pharmacies terminal market growth.
But there has been good news. Reporter noticed, on August 7, shenyang drug supervision bureau said that the retail pharmacies are exploring propulsion "card" reform, for at the same time, management of drugs, medical devices, health food retail pharmacies, executes one-time when its pharmaceutical trading license application, one-time acceptance, one-time review, one-time on-site inspection, grant licences and unity within 15 working days, shorten time limit for examination and approval of 82%; On August 3, the liaoning province government general office issued "on further reform and improve the pharmaceutical production circulation use policy implementation opinion", the medical institution shall not be restricted with outpatient prescription to retail pharmacy to buy medicine. The promulgation and implementation of the series of policies will undoubtedly open the green channel for the future development of retail pharmacies.
The share of chemical medicine is slightly higher
In 2016, the share of chemical drugs in China's physical drugstores was 52.01%, and the proportion of Chinese medicines accounted for 47.99%
According to the blue book, sales of Chinese retail pharmacies (including pharmaceuticals and non-pharmaceuticals) sold at a rate of 49.29 billion yuan in 2016, with a growth rate of 10.5 percent. Among them, the entity stores (including drug and non-drug) sales scale is 464.4 billion yuan, accounting for 94.2% of the share, the growth rate of 7.6%, online pharmacies (including drug and non-drug) sales scale is 28.5 billion yuan, accounting for 5.8% of the share, the growth rate of 96.7%. In 2016, the average size of each physical drug store (including drugs and non-pharmaceutical products) reached 1039,000 yuan, up 7.9% from 2015, which is related to the consumption capacity of the population and the promotion of drug prices.
In 2016, the sales of pharmaceutical products in retail pharmacies were 337.5 billion yuan, up 8.5% compared with the same period last year, and the size of drugs in both physical and online pharmacies was 332.7 billion yuan and 4.8 billion yuan respectively.
In 2016, according to the entity of pharmacy drugs accounted for 72.6%, up 1.2% year on year, influenced by entities pharmacy reimbursement policy, the drug is still a main category of entity pharmacy, medicine class accounted for a small rise, and health care products, equipment class proportion are declining.
In 2016, the share of chemical drugs in China's physical drugstores was slightly higher, at 52.01 percent, and the proportion of Chinese medicines accounted for 47.99 percent. According to the classification of chemical drug market in physical pharmacy, Rx occupies a dominant position, and its market share is significantly higher than that of OTC and dual-span varieties. In 2016, Rx accounted for 67.66% of the pharmaceutical market in the physical pharmacy, with OTC accounting at 30.50%, while the dual-span variety accounted for 1.84%.
Another concern is the performance of Chinese medicine. In 2016, a series of policies including the outline of China's strategic planning for development of traditional Chinese medicine (2016-2030) and the 13th five-year plan for traditional Chinese medicine (TCM) have been launched. According to the blue book analysis, as an important pillar of traditional Chinese medicine, Chinese medicine has taken up considerable scale in physical medicine stores, with the largest proportion of sales of OTC drugs in China, 56.57%. The second is Rx, which accounts for 27.16%. Double span ratio 16.27%.
These varieties sell well
Slow medicine and common diseases are the main drivers of growth in the retail pharmacy market
M network analysis, points out that in 2016 China's urban retail pharmacies terminal chemical medicine from the point of growth, blood and hematopoietic system drugs, reproductive and urinary system relatively high growth of sex hormone drugs and respiratory system, muscle - skeletal system, cardiovascular system, the growth of these three kinds of drugs are also considerable.
"Blue book", according to data from the digestive system and metabolism of drugs, cardiovascular system, the whole body with anti-infection drugs and respiratory medicine for domestic entities pharmacy chemical medicine market share in the first four city, the most popular breed in the first four are respectively atorvastatin calcium tablet, clopidogrel bisulfate tablet, sildenafil citrate tablets, benzene sulfonic acid amlodipine.
The market share of the drug market is the highest in the market for respiratory diseases, bone and muscle diseases, and the market share of the drugs for the digestive system. At the top of the list is the supplement of the gas supplement, which is the TOP1 of the market share of China's pharmaceutical products, accounting for 5.99% of the market share.
In general, the use of chronic disease drugs and common diseases has become the main driving force for the growth of retail pharmacies.
In fact, China has fully entered an aging society and is expected to exceed 300 million by 2030 and a third of its population by 2050. Based on the medical and health resources insufficiency, the quality is not high, and the effective complement of pharmacy as medical and health resources, with the aging of the population continues to grow, to slow disease drug market blowout.
In response, industry sources suggest that "managing the slow disease management means consolidating the customer base of the drugstore and seeking greater survival and development in the competitive retail market."
|
| |
Previous article：Imported medicine, hemophilia domestic varieties are under threat
Next article：Xi: accelerate the establishment of a basic medical and health system with Chinese characteristics
|
| |
|
|
